Skip to content

SARIMED

Active
Private limited companyfounded 201511 yrs activeKBO/BCE: BE 0634.636.455
Summary

SARIMED has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €16,684 and a net result of -€3,971. Equity is growing by ~7.3% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 1.4% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability0▼-97
Solvency100=
Growth35▼-17
Track record100
Bankruptcy probability, 12 months
1.4% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1,000 at 30 days acceptable
cash: 85.6% of total assets, and 0% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Three signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
100%
Return on assets
-23.8%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-09-2026, 50 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filings
Deviation from the deadline
2025
50 d late
2024
50 d late
2023
288 d late
2021
191 d late
2020
142 d late
2018
19 d early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 6 accounts on average 117 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 27 July 2015, SARIMED was incorporated.1 Total assets went from EUR 9,373 in 2018 to EUR 16,684 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Turnover
€9,967▼ 54.4%
2020 · €21,841
EBIT margin
-1.6%
Net result
-€3,971
2024 · €5,489
Working capital
€20,655▲ 36.2%
2023 · €15,166
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202021202320242025
Turnover€21,841-€9,967▼ 54.4%
Operating result-€163€3,324-€5,773▲ 73.7%-€2,035
Net result€691--€163€1,716-€5,489▲ 220%-€3,971
EBIT margin-1.6%
Equity€13,613-€13,450▼ 1.2%€15,166-€20,655▲ 36.2%€16,684▼ 19.2%
Total assets€13,613-€13,994▲ 2.8%€15,710-€23,029▲ 46.6%€16,684▼ 27.6%
Debt€544€544-€2,374▲ 336%
Working capital€13,450€15,166-€20,655▲ 36.2%
Result per fiscal year
Operating resultNet result
-€5,000-€2,500€0€2,500€5,000Net result 2020: €691€691Operating result 2021: -€163-€163Net result 2021: -€163-€163Operating result 2023: €3,324€3,324Net result 2023: €1,716€1,716Operating result 2024: €5,773€5,773Net result 2024: €5,489€5,489Operating result 2025: -€2,035-€2,035Net result 2025: -€3,971-€3,97120202021202320242025-€5,000-€2,500€0€2,500€5,000Operating result 2023: €3,324€3,320Net result 2023: €1,716€1,720Operating result 2024: €5,773€5,770Net result 2024: €5,489€5,490Operating result 2025: -€2,035-€2,030Net result 2025: -€3,971-€3,970202320242025
The operating result turns negative in 2025: a loss of €2,035 after €5,773 in 2024, the lowest result in the available series.
Key figures and ratios
2025 value · change against 2024
Solvency
100.0%▲
2024 · 89.7%
ROE
-23.8%▼
2024 · 26.6%
ROA
-23.8%▼
2024 · 23.8%
Income taxes
€2,315
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 4,815 companies that looked in July 2024 the way this one looks now, 1.9% went bankrupt within 24 months and 88% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more
1.9% went bankrupt
9.9% stopped otherwise
88% still going

A further 0.5% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 1.4% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 4,815 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 27 lines
Balance sheet Code20242025
Assets
Total assets20/58€23,029€16,684▼
Current assets29/58€23,029€16,684▼
Amounts receivable within one year40/41€9,583€2,409▼
Other amounts receivable41€9,583€2,409▼
Cash at bank and in hand54/58€13,447€14,275▲
Equity and liabilities
Total equity and liabilities10/49€23,029€16,684▼
Equity10/15€20,655€16,684▼
Contributions10/11€12,457€12,457=
Outside capital11€12,457€12,457=
Other1109/19€12,457€12,457=
Profit (loss) carried forward14€8,198€4,227▼
Amounts payable17/49€2,374-
Amounts payable within one year42/48€2,374-
Trade debts44€2,374-
Suppliers440/4€2,374-
Income statement Code20242025
Gross operating margin9900€5,773-€2,035▼
Operating profit (loss)9901€5,773-€2,035▼
Financial income75/76B-€562
Recurring financial income75-€562
Financial charges65/66B€284€183▼
Recurring financial charges65€284€183▼
Profit (loss) for the period before taxes9903€5,489-€1,656▼
Income taxes67/77-€2,315
Profit (loss) for the period9904€5,489-€3,971▼
Profit (loss) for the period to be appropriated9905€5,489-€3,971▼
Appropriation of the result
Profit (loss) to be appropriated9906€8,198€4,227▼
Profit (loss) brought forward from the previous period14P€2,709€8,198▲
Line20202021202320242025Change
Turnover70€21,841€9,967----
Goods, raw materials, services and sundry goods60/61-€10,130€3,347---
Remuneration, social security and pensions62--€660---
Gross operating margin9900--€163€3,984€5,773-€2,035▼ 135%
Operating profit (loss)9901--€163€3,324€5,773-€2,035▼ 135%
Financial income75/76B----€562-
Recurring financial income75€839---€562-
Financial charges65/66B--€346€284€183▼ 35.5%
Recurring financial charges65€148-€346€284€183▼ 35.5%
Profit (loss) for the period before taxes9903€691-€163€2,978€5,489-€1,656▼ 130%
Income taxes67/77--€1,262-€2,315-
Profit (loss) for the period9904€691-€163€1,716€5,489-€3,971▼ 172%
Profit (loss) for the period to be appropriated9905€691-€163€1,716€5,489-€3,971▼ 172%
Line20202021202320242025Change
Assets
Total assets20/58€13,613€13,994€15,710€23,029€16,684▼ 27.6%
Current assets29/58€13,613€13,994€15,710€23,029€16,684▼ 27.6%
Amounts receivable within one year40/41€3,480-€2,248€9,583€2,409▼ 74.9%
Other amounts receivable41--€2,248€9,583€2,409▼ 74.9%
Cash at bank and in hand54/58€10,133€13,994€13,462€13,447€14,275▲ 6.2%
Equity and liabilities
Total equity and liabilities10/49€13,613€13,994€15,710€23,029€16,684▼ 27.6%
Equity10/15€13,613€13,450€15,166€20,655€16,684▼ 19.2%
Contributions10/11€12,457€12,457€12,457€12,457€12,457=
Capital10-€12,457€12,457---
Issued capital100-€18,600€18,600---
Uncalled capital101-€6,143€6,143---
Outside capital11---€12,457€12,457=
Other1109/19---€12,457€12,457=
Profit (loss) carried forward14€1,156€993€2,709€8,198€4,227▼ 48.4%
Amounts payable17/49-€544€544€2,374--
Amounts payable within one year42/48-€544€544€2,374--
Trade debts44---€2,374--
Suppliers440/4---€2,374--
Other amounts payable47/48-€544€544---
Line20202021202320242025Change
Profit (loss) for the period9904€691-€163€1,716€5,489-€3,971▼ 172%
Operating cash flow (approximation)€691-€163€1,716€5,489-€3,971▼ 172%
Change in cash-€3,861--€15€828▲ 5,544%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
19-09
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 50 days late
2025
31-12
Financial Weakest financial yearnet -€3,971
Net result drops to -€3,971, the lowest in the series.
19-09
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 50 days late
15-05
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 288 days late
2024
31-12
Financial Highest result since 2018net €5,489 ▲220%
Net result €5,489, the highest in the series.
2023
31-12
Financial Back to profitnet €1,716
Net result €1,716 after one loss-making year.
07-02
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 191 days late
2021
20-12
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 142 days late
2020
31-12
Financial Back to profitnet €691
Net result €691 after one loss-making year.
2019
12-07
NBB filing Annual accounts filed
fiscal year 2018 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Anderlecht · 1 establishment unit since 2015
seat establishment The establishment unit on the map
Ground area
233 m²
Building footprint
233 m²
Volume, LiDAR
2,109 m³
Parcel 21302A0041/00S000, Brussels · tallest building 12.1 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Establishment
General medical practice
since 20152.248.222.646
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21302A0041/00S000 Brussels 233 m² 1 · 233 m² 12.1 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded27-07-2015
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:0634636455
Also 9925:BE0634636455
Registered 08-12-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.